Page last updated: 2024-08-25

terlipressin and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

terlipressin has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Golestaneh, L; Neugarten, J1
Kim, JW1
Chang, FY; Hou, MC; Huang, YT; Lee, FY; Lee, SD; Lee, WC; Lin, HC; Yang, YY1

Reviews

1 review(s) available for terlipressin and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

ArticleYear
Dual Organ Duel: The Hepatorenal Axis.
    Advances in chronic kidney disease, 2017, Volume: 24, Issue:4

    Topics: Acute Kidney Injury; Animals; Antihypertensive Agents; Antiviral Agents; Cytochrome P-450 Enzyme System; Hepatitis C; Hepatorenal Syndrome; Humans; Liver Diseases; Lypressin; Renal Insufficiency, Chronic; Terlipressin

2017

Trials

1 trial(s) available for terlipressin and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

ArticleYear
Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis.
    Scandinavian journal of gastroenterology, 2002, Volume: 37, Issue:4

    Topics: Aged; Cardiac Output; Drug Therapy, Combination; Female; Hemodynamics; Hepatitis B; Hepatitis C; Humans; Hypertension, Portal; Infusions, Intravenous; Injections, Intravenous; Liver Circulation; Liver Cirrhosis; Lypressin; Male; Middle Aged; Octreotide; Terlipressin; Vascular Resistance; Vasoconstrictor Agents; Venous Pressure

2002

Other Studies

1 other study(ies) available for terlipressin and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

ArticleYear
[Type 2 hepatorenal syndrome in a cirrhotic patient who underwent gastric cancer surgery].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2010, Volume: 56, Issue:3

    Topics: Adult; Hepatitis C; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Male; Portasystemic Shunt, Transjugular Intrahepatic; Stomach Neoplasms; Terlipressin; Tomography, X-Ray Computed; Vasoconstrictor Agents

2010